Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
63 studies found for:    PRADER-WILLI SYNDROME
Show Display Options
Rank Status Study
1 Completed Oxytocin Trial in Prader-Willi Syndrome
Condition: Prader Willi Syndrome
Interventions: Drug: Intranasal oxytocin;   Other: Placebo
2 Completed Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: DCCR;   Drug: Placebo
3 Completed Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Norditropin SimpleXx
4 Recruiting Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years
Condition: Prader-Willi Syndrome
Interventions: Drug: Oxytocin;   Drug: Placebo
5 Completed Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: RM-493;   Drug: Placebo
6 Unknown  Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell
Condition: Prader-Willi Syndrome
Intervention: Drug: Recombinant Somatropin
7 Unknown  Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Device: Deep Brain Stimulation
8 Terminated
Has Results
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
Condition: Prader-Willi Syndrome
Interventions: Drug: Octreotide;   Drug: Placebo
9 Recruiting Register of Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Other: Data collection
10 Unknown  Growth Hormone Use in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Nutropin AQ
11 Recruiting Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: Oxytocin continuous;   Drug: Placebo;   Drug: Placebo continuous;   Drug: Oxytocin
12 Completed Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
Condition: Prader-Willi Syndrome
Intervention:
13 Unknown  Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Exenatide
14 Not yet recruiting Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory
Condition: Prader-Willi Syndrome
Intervention: Behavioral: Listening Project Protocol
15 Not yet recruiting Cannabidiol Oral Solution for The Treatment of Subjects With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: Cannabidiol;   Drug: Placebo
16 Completed Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks
Condition: Prader-Willi Syndrome
Interventions: Drug: Topiramate;   Drug: Placebo Comparator
17 Recruiting Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.
Condition: Prader-Willi Syndrome
Interventions: Drug: Oxytocin;   Other: Control
18 Recruiting Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: Eutropin;   Drug: Genotropin
19 Completed
Has Results
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Exenatide
20 Unknown  Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Condition: Prader-willi Syndrome
Interventions: Drug: rimonabant;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.